Literature DB >> 7440462

Treatment of urinary tract infections in general practice with sulfamethizole, trimethoprim or co-trimazine (sulphadiazine-trimethoprim).

C E Mabeck, R Vejlsgaard.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7440462     DOI: 10.1093/jac/6.6.701

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  4 in total

1.  Co-trimoxazole toxicity.

Authors:  R W Lacey; P M Hawkey; S K Devaraj; M R Millar; T J Inglis; P G Godwin
Journal:  Br Med J (Clin Res Ed)       Date:  1985-08-17

2.  A Trimethoprim Conjugate of Thiomaltose Has Enhanced Antibacterial Efficacy In Vivo.

Authors:  Xiaojian Wang; Clarissa A Borges; Xinghai Ning; Mohammad Rafi; Jingtuo Zhang; Bora Park; Kiyoko Takemiya; Carlo Lo Sterzo; W Robert Taylor; Lee Riley; Niren Murthy
Journal:  Bioconjug Chem       Date:  2018-04-25       Impact factor: 4.774

3.  Effects of sulfamethizole and amdinocillin against Escherichia coli strains (with various susceptibilities) in an ascending urinary tract infection mouse model.

Authors:  M B Kerrn; N Frimodt-Møller; F Espersen
Journal:  Antimicrob Agents Chemother       Date:  2003-03       Impact factor: 5.191

4.  Pivmecillinam versus sulfamethizole for short-term treatment of uncomplicated acute cystitis in general practice: a randomized controlled trial.

Authors:  Lars Bjerrum; Bente Gahrn-Hansen; Per Grinsted
Journal:  Scand J Prim Health Care       Date:  2009       Impact factor: 2.581

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.